위장관계 악성종양에서 CA 125 측정의 의미

장우익 ( Jang U Ig ),안강현 ( An Gang Hyeon ),이종인 ( Lee Jong In ),김현수 ( Kim Hyeon Su ),김효열 ( Kim Hyo Yeol ),김수경 ( Kim Su Gyeong ),이동기 ( Lee Dong Gi ),배선우 ( Bae Seon U ),심영학 ( Sim Yeong Hag ),강명서 ( Kang Myeo 대한내과학회 1993 대한내과학회지 Vol.44 No.4

연구배경 : 종양표지자는 암외 진단, 임상적 병기구분 및 치료효과 판정에 유용하며, 위장관암에서 alphafetoprotein, carcinoembryonic antigen, CA 19-9, 및 CA 72-4 등이 중요한 지표로 사용되고 있으나 위암의 경우, 현재까지 만족할 만한 유용성을 가진 종양표지자는 없는 실정이다. 저자등은 위암에 대한 새로운 종양표지자로 CA 125의 역할을 규명하고자 위암을 비롯한 각종 위장관암에서 CA 125와 기존의 종양표지자와의 유용성을 검토하였다. 방법 : 대상은 위장관 악성종양 181예, 위장관 양성질환자 55예를 대상으로 하였으며 CA 72-4는 CIS ELSA CA 72-4 RIA kit, CA 19-9는 Abbott CA 19-9 RIA kit, CEA는 Abbott CEA kit, CA 125는 Centocor CA 125 RIA kit를 사용하여 측정하였으며, 각각의 정상치 한계는 4 U/ml, 37 U/ml, 5ng/ml그리고 35 U/ml로 하였다. 결과 : 1) CA 125는 양성 소화기 질환에서 93%의 높은 특이도를 보였으나 복수가 있는 간경변증의 경우 거의 전예에서 혈중 CA 125값이 증가하여 악성종양군과 감별이 어려웠다. 2) CA 125는 위암에서 민감도가 36%로 CA 72-4와 차이가 없었다. 3) CA 125는 췌담도암에 대한 민감도가 55%로 CA 19-9의 85%에 비해 낮았으며 두 종양표지자를 병합하여 사용한 경우 민감도의 증가(95%)를 볼 수 있었다. 4) 23예의 조기위암 환자에서 CA 125의 민감도는 9%로 낮았다. 5) Conventional image study 상으로 인지되지 않은 복강내 암종증 환자에 대한 CA 125의 민감도는 36%였다. 결론 : CA 125는 위암에서 기존의 종양표지자인 CA 72-4와 유용성의 차이를 보이지 않았으며 전이성 위암에서 높은 민감도를 나타내었다. 혈중 CA 125의 증가는 위장관의 악성 및 양성질환에 관계없이 복수의 유무와 밀접한 연관관계를 가지는 것으로 사료되며 통상적인 영상 진단법상으로 인지되지 않은 복강내 암종중의 예견에 있어서는 유용하지 않을 것으로 생각된다. Background: Detection of tumor markers could offer an accessible method for screening risk groups in order to achieve an early diagnosis of cansers, to contribute to and adequate staging, and to help evaluate effects of therapy. CA 125 is an antigenic determinant defined by murine monoclonal antibody OC 125, and synthesized by coelomic epithelial derivatives such as Mullerian epithelium and mesothelial tissues. CA 125 is regarded as useful tumor marker for non-musinous epithelial ovarian tumors. So we investigated whether CA 125 is reliable tumor marker for gastrointestinal malignancies and especially for detection of intraperitoneal carcinomatosis unrecognized by conventional imaging studies. And we compared CA 125 with other conventional tumor markers in the serodiagnosis of gastrointestinal malignancies. Methods: Serum CA 72-4, CA 19-9, CA 125 and CEA were determined radioimmunologically with monoclonal antibodies. A cut-off value of 4 U/ml, 37 U/ml, 35 U/ml and 5 mg/ml were used respectively. Results: The results are summarized as follows. 1) CA 125 had high specificity (93%) for benign gastrointestinal disease but was not useful to differetiate malignant ascites and benign ascites. 2) In gastric carcinoma, the sensitivity of CA 125 (36%) was not so different to that of CA 72-4(36%). 3) In pancreatobiliary carcinoma, the sensitivity of CA 125(55%) was inferior than that of CA 19-9 (85%), but combined use of these two tumor markers increases sensitivitu(95%) for the diagnosis. 4) The sensitivities of CA 125 for 23 early gastric cancer was 9%. 5) The sensitivities of CA 125 for the intraperitoneal carcinomatosis that was not recognized by conventional imaging studies was 36%. Conclustion: Our data indicates that CA 125 is not better in the serodiagnosis of gastrointestinal malignancies than other conventional tumor markers, and CA 125 has a little predictive value in the diagnosis of intraperitoneal carcinomatosis unrecognized by the conventional imaging studies. Serum CA 125 elevation in benign or malignant diseases closely correlated with the presence of ascites.

SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of “cancer cells with neural stemness” in a p53-dependent manner

Lee, Ji-Seon,Park, Jeong-Rak,Kwon, Ok-Seon,Lee, Tae-Hee,Nakano, Ichiro,Miyoshi, Hiroyuki,Chun, Kwang-Hoon,Park, Myung-Jin,Lee, Hong Jun,Kim, Seung U.,Cha, Hyuk-Jin Oxford University Press 2015 Neuro-oncology Vol.17 No.1

<P><B>Background</B></P><P>Cancer stemness, observed in several types of glioma stem cells (GSCs), has been demonstrated to be an important barrier for efficient cancer therapy. We have previously reported that cancerous neural stem cells (F3.Ras.CNSCs), derived from immortalized human neural stem cells by a single oncogenic stimulation, form glial tumors in vivo.</P><P><B>Method</B></P><P>We searched for a commonly expressed stress modulator in both F3.Ras.CNSCs and GSCs and identified silent mating type information regulation 2, homolog (SIRT1) as a key factor in maintaining cancer stemness.</P><P><B>Result</B></P><P>We demonstrate that the expression of SIRT1, expressed in “cancer cells with neural stemness,” is critical not only for the maintenance of stem cells, but also for oncogenic transformation. Interestingly, SIRT1 is essential for the survival and tumorigenicity of F3.Ras.CNSCs and GSCs but not for the U87 glioma cell line.</P><P><B>Conclusion</B></P><P>These results indicate that expression of SIRT1 in cancer cells with neural stemness plays an important role in suppressing p53-dependent tumor surveillance, the abrogation of which may be responsible not only for inducing oncogenic transformation but also for retaining the neural cancer stemness of the cells, suggesting that SIRT1 may be a putative therapeutic target in GSCs.</P>

가평 전주이씨묘 출토복식 고찰

최연우,박윤미,김윤경,김지희,박양희,이선우,차서연,편나영,황혜남,Choi, Yeon Woo,Park, Yoon Mee,Kim, Yoon Gyung,Kim, Ji Hee,Park, Yang Hee,Lee, Seon U,Cha, Seo Yeon,Pyeon, Na Young,Hwang, Hye Nam 한국의류학회 2017 한국의류학회지 Vol.41 No.5

In 1995, the costumes were restored in an unknown woman's tomb at the Jeonju Lee's family cemetery in Gapyeong, Gyeonggi-Do, and there are currently nine items remaining. In this study, we first introduced these 9 relics to academia and analyzed the morphological characteristics of the costumes. We also estimated the time and person of burial compared with costumes unearthed from other burials. Jeogories (short jacket) are all four items. One of these items was unusual in shape, and the upper part of the seop (gusset) was wrinkled and shaped. This type of Jeogori appears only till the 1520s in other tombs. There are also two skirts, one of which is characterized by a superimposed pattern. The top and bottom / middle part of the skirt were rolled up, and the skirt, which was double-rolled up in this way, was first discovered. An analysis of the shape of Jeogori and skirt indicated that the person buried in the Jeonju Lee's family tomb was believed to have survived until the early 16th century. Based on these estimated periods, as a result of looking at the genealogy of Jeonju Lee's family, it was concluded that the tomb was probably a woman named Lee Geum Myeong (李金命) born in the mid-15C and died between the late 15C and the early 16C.

子宮內膜搔爬術 21例의 鍼麻醉效果에 대한 臨床的 硏究

金在圭,金相佑,李宜暻,金建植,金相佑,南相永 경희대학교 1997 慶熙醫學 Vol.13 No.1

전치부 반대교합을 동반한 환자에서의 수직고경 회복

계기성,최우식,이선아 조선대학교 구강생물학연구소 2002 Oral Biology Research (Oral Biol Res) Vol.26 No.2

In cases of anterior crossbite patients, there are many problems. They are dissatisfied with facial appearance and in difficulties for speaking, and sometimes are related to reduced vertical dimension. Vertical dimension is defined distances between two points which one is on maxilla and the other is on mandible. Loss of vertical dimension may causes temporomandibular disorder, loss of masticatory function, and collapse of occlusion. This is a clinical study of 50 years old male with reduced vertical dimension and anterior-crossbite. We treated patient with fixed bridge and conventional removable partial denture, and then the activity of masseter and temporalis muscle were recorded and analyzed by means of Biopak?? system(Bioresearch Inc., Millwakee Wisconsin). The result was satisfactory functionally and esthetically.

HBV : Retrospective Observational Study to Evaluate the Efficacy of Entecavir in Patients with Chronic Hepatitis B Virus Infection in Korea: Real-Life Clinical Outcomes

( Chung-Hwa Park ),( Sung Won Lee ),( Hee Yeon Kim ),( Do Seon Song ),( Hyun Jin Kim ),( Myeong Jun Song ),( Jung Hyun Kwon ),( Chan Ran You ),( Jeong Won Jang ),( U Im Chang ),( Chang Wook Kim ),( So 대한간학회 2013 춘·추계 학술대회 (KASL) Vol.2013 No.1

Background: Entecavir, has demonstrated superior histologic, virologic, and biochemical benefit. Still, its long-term clinical outcome is not well established in the Korean clinical area, and also in subjects who stopped the treatment. Methods: This is a multicenter, retrospective cohort observational study to evaluate the efficacy of Entecavir long-term treatment in CHB patients at hospitals affiliated to the Catholic University of Korea through analysis of the electronic medical record data from January 1, 2006 to December 31, 2012. Results: Among 2,440 patients prescribed with entecavir 0.5mg qd, 1,337 patients were treatment naive. Excluding 533 patients with concomitant conditions, 578 patients were ontreatment and 226 patient stopped entecavir during the study period. At 6mo, year 1, 2, 3, 4 and 5, cumulative incidences of complete virologic response (HBV-DNA < 300 copies/mL) was 379, 530, 573, 577, 579 and 579, respectively. HBsAg loss rate was 9.86%, and among 440 HBeAg-positive patients, HBeAg loss rate and HBeAg loss with HBeAb positivity rate was 20.00% and 17.43%, respectively, at year 1. During the study period, 226 patients stopped entecavir, and at year 1 after cessation, cumulative virologic relapse (HBV-DNA>10^4 copies/ mL) and biochemical relapse (ALT>40 U/L) were 22.57% and 20.35%, respectively with mean days of 191.06±67.0 and 188.39±90.15, respectively. Prognotsic factor for earlier CVR was HBV-DNA<10^7cpm at initiating entecavir (P<0.005). Among those who stopped the medication, prognostic factor for virological relapse was HBV-DNA ≥10^7cpm at initiating entecavir (P=0.022). Conclusions: Long term use of entecavir may achieve CVR in most patients, and patients with higher viral load should be considered of indefinite duration of treatment regardless of age, sex, biochemical markers or HBeAg status.

크롬계 탄화물의 분포와 형태가 니켈계 합금 600의 염기응력부식에 미치는 영향

김선재,최종호,성진경,김우곤,박순동,이창규,정용환,국일현,Kim, Seon-Jae,Choe, Jong-Ho,Seong, Jin-Gyeong,Kim, U-Gon,Park, Sun-Dong,Lee, Chang-Gyu,Jeong, Yong-Hwan,Guk, Il-Hyeon 한국재료학회 1998 한국재료학회지 Vol.8 No.8

32$0^{\circ}C$, 40%NaOH 용액의 autoclave에서 약 300wppm의 탄소를 함유하고 있는 15Cr-9Fe-balanced Ni 합금 판상시편에 대해 응력부식 저항성을 조사하였다. 부식시편은 $700^{\circ}C$, 100시간 동안의 열처리로 합금내부에 석출될 수 있는 가능한 한 많은 양의 크롬계 탄화물을 석출시킨 후, 다시 재용해에 의해 크롬계 탄화물의 형태를 조절하는 $800^{\circ}C$-$950^{\circ}C$범위의 최종열처리를 시행하고 급냉시킨 다음 U-자형으로 응력을 가하여 준비되었다. 최종열처리 온도가 올라감에 따라 시편들의 입계응력부식균열(IGSCC ) 전파속도는 $900^{\circ}C$까지는 거의 직선적으로 증가하다가 $950^{\circ}C$에서는 $700^{\circ}C$에서 얻은 값보다도 더 낮게 감소하였다. 즉, 크롬계 탄화물이 재용해되어 그 밀도가 감소함에 따라 IGSCC저항성이 감소하다가 완전히 재용해된 $950^{\circ}C$ 열처리 조건에서 오히겨 가장 큰 IGSCC 저항성을 나타내었다. 이와같은 최조열처리 온도에 따른 니켈계 합금 600의 부식거동은 입계에 존재하는 크롬계탄화물의 형태변화 때문이 아니라 입계에서 탄소-크롬계 탄화물-크롬간의 상평형에 의해 이루어지는 탄소의 입계편석량이 크롬계탄화물이 존재할 때에는 열처리 온도에 따라 증가하다가 그것이 완전히 재용해 되었을 때 가장 낮아지기 때문인 것으로 생각된다.

Hepatitis B Reactivation among Chronic Hepatitis C Patients Treated with Direct Acting Antivirals

( Hee Yeon Kim ),( Chang Wook Kim ),( Jin Ah Kim ),( Mi Ju Cheon ),( Chan Ran You ),( Sang Wook Choi ),( Se Hyun Cho ),( Joon-Yeol Han ),( Do Seon Song ),( U Im Chang ),( Jin Mo Yang ),( Sung Won Lee 대한간학회 2017 춘·추계 학술대회 (KASL) Vol.2017 No.1

Aims: This study aimed to investigate hepatitis B virus (HBV) reactivation among hepatitis C virus (HCV) infected patients treated with oral direct acting antiviral (DAA) therapy in areas endemic for HBV in Korea. Methods: A total of 821 HCV-infected patients receiving oral DAA therapy from March 2015 to November 2016 were evaluated. Serum HBV DNA and HCV RNA was regularly assessed during and after DAA treatment in patients with HBV-HCV coinfection. HBV virological reactivation was defined as a >1 log increase in HBV DNA from baseline or a reappearance of HBV DNA for those with baseline undetectable HBV DNA. Clinical reactivation was defined as a serum alanine aminotransferase level ≥3-fold over the upper limit of normal or > 100 U/L. Results: Prior to DAA therapy 95.8% (787/821) had HBsAg testing and 1.7% (13/787) were positive. HBV virological reactivation was found in 7 (53.8%) of the 13 patients. HBV-related clinical reactivation was not observed in our cohort. Conclusions: For HBV-HCV co-infected patients, the risk of HBV virological reactivation was present after oral DAA treatment for HCV infection. Monitoring the HBV DNA level during oral DAA therapy for HCV infection is warranted.

Eccrine poroma mimicking keratoacanthoma on the forehead

( Seon Gu Lee ),( Go Woon Choi ),( Seung Hui Seok ),( Ji Hae An ),( Jung U Shin ),( Hyun Jung Kim ),( Dong Hyun Kim ),( Moon Soo Yoon ),( Hee Jung Lee ) 대한피부과학회 2019 대한피부과학회 학술발표대회집 Vol.71 No.1

Eccrine poroma is a common, slow-growing solitary adnexal tumor originating from the intraepidermal ductal portion of the eccrine sweat duct. It can occur anywhere on the body where eccrine gland exists and most commonly found on the sole and palm. It usually occurs in middle-aged or elderly adults as a solitary, asymptomatic flesh-colored or pink nodule. A 63-year-old man visited our clinic with a solitary, 1 cm sized erythematous nodule with central umbilication on the forehead which had developed 1 year ago. Initial impression was keratoacanthoma, considering the characteristic clinical features and site of lesion. A punch biopsy was performed for accurate diagnosis. Histologic findings indicated the broad anastomosing bands of monomorphic cuboidal cells with intercellular bridges and occasional ductal lumina growing downward into the dermis. Eccrine poroma was diagnosed based on the histologic findings. The patient was treated by complete excision. The skin lesion was completely removed and there was no recurrence to date. Herein, we report a case of eccrine poroma on the forehead that clinically mimicked keratoacanthoma. Physicians should be aware of this possibility and perform a histopathologic evaluation to facilitate an accurate diagnosis.

A case of acantholytic acanthoma on unusual site

( Seon Gu Lee ),( Go Woon Choi ),( Seung Hui Seok ),( Ji Hae An ),( Jung U Shin ),( Hyun Jung Kim ),( Dong Hyun Kim ),( Moon Soo Yoon ),( Hee Jung Lee ) 대한피부과학회 2019 대한피부과학회 학술발표대회집 Vol.71 No.1

Acantholytic acanthoma is a newly recognized, solitary benign tumor in which acantholysis is the hallmark. It was first described by Brownstein in 1985. It usually presents as an asymptomatic keratotic papule or nodule on the trunk. The histologic pattern resembles that seen in pemphigus or Hailey-Hailey disease. To our knowledge, only few cases have been reported as acantholytic acanthoma on the face. A 66-year-old woman visited our clinic with a solitary, 0.7 cm sized erythematous plaque on the forehead which had developed 1 year ago. A punch biopsy specimen revealed hyperkeratosis, acanthosis and marked acantholysis with a suprabasal acantholytic cleft. Dyskeratotic cells such as corps ronds or grains were not prominently observed. Acantholytic acanthoma was diagnosed based on the clinical and histologic findings. The patient is under observation without other treatments. Herein, we report a case of acantholytic acanthoma on the face which is an unusual site with review of the literature.